EYES ON WHAT MATTERS IN IRDs
The AMERICAN ACADEMY OF OPHTHALMOLOGY recommends genetic testing for most patients with a suspected inherited retinal disease (IRD) to confirm diagnosis, guide management, inform family planning, and determine eligibility for clinical trials.1
90% support testing*
Data from over 200 patients with IRDs showed that 90% view genetic testing as a positive step forward in their patient journey.2
~7% visual field loss†
Patients with retinitis pigmentosa (RP) experience varying rates of vision loss. Those with X-linked retinitis pigmentosa (XLRP) experience the most severe manifestations, with a visual field decline of ~7% every year, greatly impacting their daily vision.3,4
40+ ongoing gene therapy trials
Over 40 ongoing clinical trials are investigating IRD gene therapy, with some showing promise to protect functional vision.5
Genetic testing gives you so much power. It gave us the key to the lock.
– Allison, mom of children living with an IRD
Genetic testing gives you so much power. It gave us the key to the lock.
– Allison, mom of children living with an IRD
*Data from a 2013 study were collected from 200 IRD patients using a 5-point Likert scale telephone questionnaire.
†Data were collected from a 2020 study of more than 1,300 medical records from the Eye Institute of Alberta and the University of Alberta Hospital. A total of 275 kinetic visual field tests were collected from 52 subjects with retinitis pigmentosa over a period of up to 29 years.